{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/22060"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/22060","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Bromethalin-based rodenticides: Mode of action, toxicity, clinical effects, and treatment efficacy in rats, dogs, and cats","abstract":"The purpose of these studies was to define the toxicity of bromethalin-based rodenticides, develop treatments, and determine new modes of action of bromethalin. Bromethalin-based rodenticides are highly neurotoxic to cats (bait LD$\\sb{50}$ 0.54 mg bromethalin/kg) and dogs (bait LD$\\sb{50}$ 3.56 mg bromethalin/kg). Bromethalin poisoning in the dog and cat produced a dose dependent delayed toxic syndrome. Sublethal doses of bromethalin to dogs and cats resulted in delayed CNS depression, hindlimb ataxia, paresis, and paralysis. Higher doses given to dogs resulted in rapid severe muscle tremors and generalized seizures. Bromethalin toxicosis was also associated with increased cerebrospinal fluid pressure and cerebral edema. Bromethalin toxicosis produces acute and chronic EEG changes. Predominant abnormal EEG changes included: spike and spike-and-wave EEG patterns; high voltage slow wave activity; photoconvulsive or photoparoxysmal irritative responses, and marked voltage depression. Histologic lesions included diffuse white matter spongiosis, mild microgliosis, and optic nerve vacuolization. Ultramicroscopic examination of brainstem revealed occasional swollen axons, intramyelenic vacuolization, and myelin splitting at the intraperiod line. Bromethalin was detected in kidney, liver, fat, and brain tissues using gas chromatography with electron capture detection. Bromethalin caused increased feline hepatic cytochrome P-450 and cytochrome b$\\sb5$ concentrations and decreased microsomal aminopyrine N-demethylase and 4-nitrophenetole-O-deethylase activities.","abstract_html":"The purpose of these studies was to define the toxicity of bromethalin-based rodenticides, develop treatments, and determine new modes of action of bromethalin. Bromethalin-based rodenticides are highly neurotoxic to cats (bait LD$\\sb{50}$ 0.54 mg bromethalin/kg) and dogs (bait LD$\\sb{50}$ 3.56 mg bromethalin/kg). Bromethalin poisoning in the dog and cat produced a dose dependent delayed toxic syndrome. Sublethal doses of bromethalin to dogs and cats resulted in delayed CNS depression, hindlimb ataxia, paresis, and paralysis. Higher doses given to dogs resulted in rapid severe muscle tremors and generalized seizures. Bromethalin toxicosis was also associated with increased cerebrospinal fluid pressure and cerebral edema. Bromethalin toxicosis produces acute and chronic EEG changes. Predominant abnormal EEG changes included: spike and spike-and-wave EEG patterns; high voltage slow wave activity; photoconvulsive or photoparoxysmal irritative responses, and marked voltage depression. Histologic lesions included diffuse white matter spongiosis, mild microgliosis, and optic nerve vacuolization. Ultramicroscopic examination of brainstem revealed occasional swollen axons, intramyelenic vacuolization, and myelin splitting at the intraperiod line. Bromethalin was detected in kidney, liver, fat, and brain tissues using gas chromatography with electron capture detection. Bromethalin caused increased feline hepatic cytochrome P-450 and cytochrome b$\\sb5$ concentrations and decreased microsomal aminopyrine N-demethylase and 4-nitrophenetole-O-deethylase activities.","abstract_has_math":true,"creators":["Dorman, David Christopher"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Veterinary Biosciences","degree_department":null,"school":null,"contributors":["Buck, William B."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-05-07T13:27:41Z","date_published":"2011-05-07T13:27:41Z","updated_at":"2026-07-22T22:25:19Z","subjects":["Health Sciences, Pharmacology","Biology, Veterinary Science"],"languages":["eng"],"rights":["Copyright 1990 Dorman, David Christopher"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["AAI9026170","(UMI)AAI9026170"],"render_values":[{"text":"AAI9026170","href":null,"code":true},{"text":"(UMI)AAI9026170","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/22060","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Buck, William B."]},{"key":"dc:creator","label":"Author","values":["Dorman, David Christopher"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011-05-07T13:27:41Z","10000-01-01","1990"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Veterinary Biosciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Health Sciences, Pharmacology","Biology, Veterinary Science"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 1990 Dorman, David Christopher"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["AAI9026170","(UMI)AAI9026170","http://hdl.handle.net/2142/22060"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The purpose of these studies was to define the toxicity of bromethalin-based rodenticides, develop treatments, and determine new modes of action of bromethalin. Bromethalin-based rodenticides are highly neurotoxic to cats (bait LD$\\sb{50}$ 0.54 mg bromethalin/kg) and dogs (bait LD$\\sb{50}$ 3.56 mg bromethalin/kg). Bromethalin poisoning in the dog and cat produced a dose dependent delayed toxic syndrome. Sublethal doses of bromethalin to dogs and cats resulted in delayed CNS depression, hindlimb ataxia, paresis, and paralysis. Higher doses given to dogs resulted in rapid severe muscle tremors and generalized seizures. Bromethalin toxicosis was also associated with increased cerebrospinal fluid pressure and cerebral edema. Bromethalin toxicosis produces acute and chronic EEG changes. Predominant abnormal EEG changes included: spike and spike-and-wave EEG patterns; high voltage slow wave activity; photoconvulsive or photoparoxysmal irritative responses, and marked voltage depression. Histologic lesions included diffuse white matter spongiosis, mild microgliosis, and optic nerve vacuolization. Ultramicroscopic examination of brainstem revealed occasional swollen axons, intramyelenic vacuolization, and myelin splitting at the intraperiod line. Bromethalin was detected in kidney, liver, fat, and brain tissues using gas chromatography with electron capture detection. Bromethalin caused increased feline hepatic cytochrome P-450 and cytochrome b$\\sb5$ concentrations and decreased microsomal aminopyrine N-demethylase and 4-nitrophenetole-O-deethylase activities.","Repeated oral administration of a superactivated charcoal/sorbitol (SAC) product was an effective therapy for bromethalin toxicosis in the dog. The administration of combined mannitol/dexamethasone were ineffective therapies in dogs or cats given lethal bromethalin doses. Delayed administration of SAC was ineffective in bromethalin-dosed cats. Extract of Gingko biloba (EGB) given (100 mg/kg) to adult male Sprague-Daley rats immediately after bromethalin (1.0 mg/kg) administration was associated with a decreases in clinical sign severity, brain malonaldehyde concentration, brain % water, and brain sodium concentration.","Bromethalin binding to cytochrome P-450 was associated with a modified Type II binding spectrum that had a peak at 420 nm and a trough at 390 nm. Hepatic cytochrome P-450 from the microsomal fractions isolated from cats given bromethalin had a similar difference spectrum (peak at 420 nm, trough at 390 nm) when compared to control cat cytochrome P-450.","Made available in DSpace on 2011-05-07T13:27:41Z (GMT). No. of bitstreams: 2 license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5) 9026170.pdf: 8260814 bytes, checksum: 664a0864b1ea783b8e1b77ad99fe176e (MD5) Previous issue date: 1990","Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:55:03Z Item is restricted indefinitely.","Restriction data tranferred 2014-07-01T11:25:38-05:00 Original Data Group with Access UIUC Users [automated] Release Date: none Reason: ETDs are only available to UIUC Users without author permission","ETDs are only available to UIUC Users without author permission","U of I Only"]},{"key":"dc:title","label":"Title","values":["Bromethalin-based rodenticides: Mode of action, toxicity, clinical effects, and treatment efficacy in rats, dogs, and cats"]}]}],"canonical_facts":{"dc:contributor":["Buck, William B."],"dc:creator":["Dorman, David Christopher"],"dc:date":["2011-05-07T13:27:41Z","10000-01-01","1990"],"dc:description":["The purpose of these studies was to define the toxicity of bromethalin-based rodenticides, develop treatments, and determine new modes of action of bromethalin. Bromethalin-based rodenticides are highly neurotoxic to cats (bait LD$\\sb{50}$ 0.54 mg bromethalin/kg) and dogs (bait LD$\\sb{50}$ 3.56 mg bromethalin/kg). Bromethalin poisoning in the dog and cat produced a dose dependent delayed toxic syndrome. Sublethal doses of bromethalin to dogs and cats resulted in delayed CNS depression, hindlimb ataxia, paresis, and paralysis. Higher doses given to dogs resulted in rapid severe muscle tremors and generalized seizures. Bromethalin toxicosis was also associated with increased cerebrospinal fluid pressure and cerebral edema. Bromethalin toxicosis produces acute and chronic EEG changes. Predominant abnormal EEG changes included: spike and spike-and-wave EEG patterns; high voltage slow wave activity; photoconvulsive or photoparoxysmal irritative responses, and marked voltage depression. Histologic lesions included diffuse white matter spongiosis, mild microgliosis, and optic nerve vacuolization. Ultramicroscopic examination of brainstem revealed occasional swollen axons, intramyelenic vacuolization, and myelin splitting at the intraperiod line. Bromethalin was detected in kidney, liver, fat, and brain tissues using gas chromatography with electron capture detection. Bromethalin caused increased feline hepatic cytochrome P-450 and cytochrome b$\\sb5$ concentrations and decreased microsomal aminopyrine N-demethylase and 4-nitrophenetole-O-deethylase activities.","Repeated oral administration of a superactivated charcoal/sorbitol (SAC) product was an effective therapy for bromethalin toxicosis in the dog. The administration of combined mannitol/dexamethasone were ineffective therapies in dogs or cats given lethal bromethalin doses. Delayed administration of SAC was ineffective in bromethalin-dosed cats. Extract of Gingko biloba (EGB) given (100 mg/kg) to adult male Sprague-Daley rats immediately after bromethalin (1.0 mg/kg) administration was associated with a decreases in clinical sign severity, brain malonaldehyde concentration, brain % water, and brain sodium concentration.","Bromethalin binding to cytochrome P-450 was associated with a modified Type II binding spectrum that had a peak at 420 nm and a trough at 390 nm. Hepatic cytochrome P-450 from the microsomal fractions isolated from cats given bromethalin had a similar difference spectrum (peak at 420 nm, trough at 390 nm) when compared to control cat cytochrome P-450.","Made available in DSpace on 2011-05-07T13:27:41Z (GMT). No. of bitstreams: 2 license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5) 9026170.pdf: 8260814 bytes, checksum: 664a0864b1ea783b8e1b77ad99fe176e (MD5) Previous issue date: 1990","Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:55:03Z Item is restricted indefinitely.","Restriction data tranferred 2014-07-01T11:25:38-05:00 Original Data Group with Access UIUC Users [automated] Release Date: none Reason: ETDs are only available to UIUC Users without author permission","ETDs are only available to UIUC Users without author permission","U of I Only"],"dc:identifier":["AAI9026170","(UMI)AAI9026170","http://hdl.handle.net/2142/22060"],"dc:language":["eng"],"dc:rights":["Copyright 1990 Dorman, David Christopher"],"dc:subject":["Health Sciences, Pharmacology","Biology, Veterinary Science"],"dc:title":["Bromethalin-based rodenticides: Mode of action, toxicity, clinical effects, and treatment efficacy in rats, dogs, and cats"],"dc:type":["text"],"thesis:degree_discipline":["Veterinary Biosciences"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:25:19Z"}